US Patent 8409589 Mutant forms of streptolysin O
Patent 8409589 was granted and assigned to Novartis on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+222 characters)
Article
Patent abstract
Forms of GAS25 (streptolysin O) which are not toxic but which still maintain the ability to induce protection against S. pyogenes are useful in vaccine compositions to induce protection against S. pyogenes.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Emiliano Chiarot0
Giuliano Bensi0
Guido Grandi0
Immaculada Margarit Y Ros0
Maria Scarselli0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08409589 Mutant forms of streptolysin O US Patent 8409589 Mutant forms of streptolysin O
Infobox
Patent Number
084095890
Patent Number
84095890
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084095890
Date of Patent
April 2, 2013
0Patent Application Number
132327640
Date Filed
September 14, 2011
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08409589 Mutant forms of streptolysin O
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08409589
Date of patent
April 2, 2013
Patent application number
13232764
Date Filed
September 14, 2011
Patent primary examiner
Find more entities like US Patent 8409589 Mutant forms of streptolysin O
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
